Free Trial
OTCMKTS:CURLF

Curaleaf Q3 2026 Earnings Results & Report

Curaleaf logo
$10.12 +0.96 (+10.50%)
As of 03:59 PM Eastern

Curaleaf beat analyst earnings expectations in its Q3 2026 results, released November 3, 2026. The company reported EPS of -$0.14 versus the -$0.16 consensus estimate.

Earnings Announcement Details

Quarter
Q3 2026
Report Date
Time
After Market Closes

Curaleaf EPS Results

Actual EPS
-$0.14
Consensus EPS
-$0.16
Beat/Miss
Beat by +$0.02
One Year Ago EPS
N/A
EPS Beat Rate
7 of last 8 quarters

Curaleaf Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Curaleaf Q3 2026 Earnings FAQ

Curaleaf (OTCMKTS:CURLF) reported earnings of -$0.14 per share for Q3 2026, beating the consensus estimate of -$0.16. The report was announced on Tuesday, November 3, 2026.

Curaleaf Earnings Headlines

I'm handing you this one free
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel
See More Curaleaf Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Curaleaf? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Curaleaf and other key companies, straight to your email.

About Curaleaf

Curaleaf (OTCMKTS:CURLF) is a cannabis company that cultivates, processes, distributes and sells cannabis products for medical and adult-use markets. Its portfolio includes cannabis flower, pre-rolls, vaporizers, concentrates, edibles, tinctures, capsules, topicals and other wellness products, offered under brands such as Curaleaf, Select and Grassroots.

The company serves customers through a network of retail dispensaries and wholesale channels in regulated U.S. cannabis markets. Its operations include cultivation and manufacturing facilities as well as dispensaries, with products distributed in multiple states where medical or adult-use cannabis is permitted. Curaleaf has also pursued international opportunities, particularly in European medical-cannabis markets.

Curaleaf traces its origins to 2010 and has expanded through organic growth and acquisitions, including the purchase of Select in 2019 and Grassroots in 2020. Boris Jordan serves as executive chairman, and Matt Darin has served as chief executive officer. The company’s shares trade over the counter under the symbol CURLF.

View Curaleaf Profile